Editor Profiles

Benjamin Ragen

Back to top

New Content Item​​​​​​​Benjamin Ragen is an Editor for the BMC-series and has been the Editor of BMC Psychology since 2017.

Before joining BioMed Central, he received his PhD in psychology at University of California at Davis, which was followed by a post-doctoral position at New York University Langone Medical Center and a second post-doctoral position at New York University.  Ben’s focus on biological psychology has involved studies on psychoneuroendocrinology, the opiate system, the neurobiology of monogamy in nonhuman primates, and pharmacological treatments for posttraumatic stress disorder.

Section Editors

Keith Laws

Back to top

New Content ItemCognitive psychology


Keith Laws is Professor of Cognitive Neuropsychology in the School of Life and Medical Sciences at the University of Hertfordshire, UK. He completed a PhD at the Department of Experimental Psychology, University of Cambridge and is the author of over 100 papers and a book entitled 'Category-Specificity: Evidence for Modularity of Mind'. He is a Chartered Psychologist, an Associate Fellow of the British Psychological Society, a Fellow of the Royal Society of Arts, a Fellow of the Institute of Learning and Teaching. He joined to Editorial Board of BMC Psychology as a Section Editor in 2013. He is also currently on the editorial boards of the British Journal of Clinical Psychology, PlosOne and World Journal of Psychiatry.

His research focuses on cognitive functioning in people suffering from neurological and psychiatric disorders including schizophrenia, Alzheimer’s disease, OCD, and body dysmorphic disorder. He has published numerous meta-analyses looking at a wide range of topics including the link between MDMA (ecstasy) drug use and poor memory, the use of ketamine as an antidepressant, sex differences in the cognitive decline associated with Alzheimer’s disease, and whether CBT reduces the symptoms of psychosis. His research has attracted national and international media attention including his work documenting worse cognitive outcomes in women suffering from Alzheimer's disease, better multitasking abilities in women than men, the impact of MDMA (ecstasy) on memory function and the use of Ketamine as an anti-depressant.